Vaxcyte Inc

Research Vaxcyte Inc (PCVX) on Bullrun: market cap USD 8.33B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerPCVX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 8.33B
• Financial periodFY2025
• Net income-USD 766.63K
• Free cash flow-USD 669.29M

Valuation Snapshot

latest market cap is USD 8.33B.

About Vaxcyte Inc

Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent carrier-sparing investigational pneumococcal conjugate vaccine (PCV) for the prevention of invasive pneumococcal disease (IPD) in infants. The company also develops VAX-31, a 31-valent, carrier-sparing investigational PCV for the prevention of IPD in adults and children;

Frequently asked questions

What is Vaxcyte Inc's market cap?

Vaxcyte Inc's market capitalization is USD 8.33B.

What does Vaxcyte Inc do?

Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.